P21-Activated Kinase 1 Mediates Compensatory Cardiac Hypertrophy that Antagonizes Pathological Cardiac Remodeling

被引：0
|
作者：
Mao, Kai [1 ]
Healy, Chastity [1 ]
Wang, Dajun [1 ]
Volden, Paul [1 ]
Gerdes, Martin [1 ]
O'Connell, Timothy [1 ]
Chernoff, Jonathan [2 ]
Liang, Qiangrong [1 ]
机构：
[1] Sanford Rsch Univ S Dakota, Sioux Falls, SD USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
CIRCULATION RESEARCH | 2008年 / 103卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P35
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [21] P21-ACTIVATED KINASE 1 IS NECESSARY FOR AN EFFICIENT AUTOPHAGY
    Tin, K.
    Huang, Y.
    Kobayashi, S.
    Liang, Q.
    CARDIOLOGY, 2017, 137 : 315 - 315
  • [22] PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction
    Knight, Walter E.
    Chen, Si
    Zhang, Yishuai
    Oikawa, Masayoshi
    Wu, Meiping
    Zhou, Qian
    Miller, Clint L.
    Cai, Yujun
    Mickelsen, Deanne M.
    Moravec, Christine
    Small, Eric M.
    Abe, Junichi
    Yan, Chen
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (45) : E7116 - E7125
  • [23] Regulation of macropinocytosis by p21-activated kinase-1
    Dharmawardhane, S
    Schürmann, A
    Sells, MA
    Chernoff, J
    Schmid, SL
    Bokoch, GM
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (10) : 3341 - 3352
  • [24] p21-Activated Kinase-Mineralocorticoid Receptor Pathway Aggravates Cardiac Inflammation and Remodeling in Hypertensive Rats with Large Blood Pressure Variability
    Yasuoka, Suguru
    Kai, Hisashi
    Kajimoto, Hidemi
    Kudo, Hiroshi
    Takayama, Narimasa
    Anegawa, Takahiro
    Aoki, Yuji
    Iwamoto, Yoshiko
    Fukuda, Kenji
    Imaizumi, Tsutomu
    CIRCULATION, 2011, 124 (21)
  • [25] Phosphoinositides Are Essential Coactivators for p21-Activated Kinase 1
    Strochlic, Todd I.
    Viaud, Julien
    Rennefahrt, Ulrike E. E.
    Anastassiadis, Theonie
    Peterson, Jeffrey R.
    MOLECULAR CELL, 2010, 40 (03) : 493 - 500
  • [26] Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis
    Wu, Mei-ping
    Zhang, Yi-shuai
    Xu, Xiangbin
    Zhou, Qian
    Li, Jian-Dong
    Yan, Chen
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (02) : 157 - 166
  • [27] Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis
    Mei-ping Wu
    Yi-shuai Zhang
    Xiangbin Xu
    Qian Zhou
    Jian-Dong Li
    Chen Yan
    Cardiovascular Drugs and Therapy, 2017, 31 : 157 - 166
  • [28] Phosphorylation of cortactin by p21-activated kinase
    Webb, Bradley A.
    Zhou, Shutang
    Eves, Robert
    Shen, Linda
    Jia, Lilly
    Mak, Alan S.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2006, 456 (02) : 183 - 193
  • [29] The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration
    Wang, Yanwen
    Wang, Shunyao
    Lei, Ming
    Boyett, Mark
    Tsui, Hoyee
    Liu, Wei
    Wang, Xin
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (08) : 1362 - 1374
  • [30] P21-Activated Kinase (Pak1) is a Direct Modulator of Cardiac Excitation-Contraction Coupling (ECC) Gain
    DeSantiago, Jaime
    Bare, Dan J.
    Sheehan, Katherine A.
    Ke, Yunbo
    Solaro, R. John
    Banach, Kathrin
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 512A - 512A
12345